![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61L 24/00 | |
A61L 24/02 | |||
A61L 27/12 | |||
A61L 27/58 |
(11) | Number of the document | 2588154 |
(13) | Kind of document | T |
(96) | European patent application number | 11734215.4 |
Date of filing the European patent application | 2011-06-30 | |
(97) | Date of publication of the European application | 2013-05-08 |
(45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/042607 |
Date | 2011-06-30 |
(87) | Number | WO 2012/003326 |
Date | 2012-01-05 |
(30) | Number | Date | Country code |
100122879 | 2011-06-29 | TW | |
361177 P | 2010-07-02 | US |
(72) |
SCHULZ, Olaf, US
HOWE, James, US
SWAIM, Rick, US
HUBER, Bryan, US
BATTS, Joel, US
HARNESS, David, US
BELANEY, Ryan, US
|
(73) |
Agnovos Healthcare, LLC,
140 Broadway, 46th Floor, New York, New York 10005,
US
|
(54) | COMPOSITION COMPRISING CALCIUM PHOSPHATE, SULFATE POWDERS OR DMB USED IN THE TREATMENT OF DEGENERATIVE BONE CONDITIONS |
COMPOSITION COMPRISING CALCIUM PHOSPHATE, SULFATE POWDERS OR DMB USED IN THE TREATMENT OF DEGENERATIVE BONE CONDITIONS |